Here the authors report that a SUMO-specific protease, SENP1, deSUMOylates RIPK1 and inhibits cell death in a mouse model of non-alcoholic fatty liver disease. Here, RIPK1 is linked to metabolic dysfunction-associated steatotic liver disease.